FDA Processing of ADR Reports

The rewrite of the NDA regulations has imposed major changes on the processing of ADR reports for both industry and government. This is one of three ten-minute presentations explaining the new ADR reporting requirements and the recent changes made by the FDA to become more responsive and capable of dealing with the new regulation. The organization and procedural changes recently implemented by the FDA and their anticipated impact are explained.